IMPLANT TECHNOLOGY

Cervical Disc Implants Implant Innovation

Advanced Biomechanical Engineering

Comprehensive overview of TGA-approved cervical disc replacement implants featuring advanced materials, biomechanical design, and proven clinical outcomes. Understanding implant technology is essential for informed decision-making about cervical disc replacement surgery.

Regulatory Clearance

Safety Standards

TGA Approved

All cervical disc implants meet strict TGA regulatory requirements ensuring safety, efficacy, and quality standards for Australian patients.

Advanced Materials

Titanium & PE

Biocompatible

State-of-the-art biocompatible materials including titanium endplates and polyethylene cores designed for long-term durability and compatibility.

Biomechanical Design

Physiological Function

Natural Motion

Sophisticated biomechanical design replicating natural cervical spine motion while providing stability and pain relief for optimal patient outcomes.

Implant Technology

Understanding Cervical Disc TechnologyEngineering Innovation for Motion Preservation

Modern artificial cervical discs represent sophisticated engineering achievements combining advanced materials science, biomechanical innovation, and proven clinical performance validated through rigorous long-term research.

Why Implant Technology Matters

Evolution of Implant Design

Current Innovation

2010s–Present

Biomimetic approaches incorporating viscoelastic properties

Key Characteristics
Polycarbonate urethane cores
One-piece viscoelastic designs
Diamond-like carbon coatings
Physiological shock absorption

Seven TGA-Approved Cervical Disc Systems

Seven major TGA-approved devices now offer complementary design approaches addressing diverse patient circumstances and surgeon preferences: PRESTIGE, Bryan, ProDisc-C, Mobi-C, MOVE-C, Baguera-C, and CP-ESP.

The Design Blueprint

Natural Cervical Disc BiomechanicsSix Degrees of Freedom

Natural cervical discs enable remarkable mobility encompassing six distinct degrees of freedom that combine to create the sophisticated motion characteristic of the healthy cervical spine. Understanding these fundamental movement patterns provides the biomechanical blueprint guiding artificial disc design.

Six degrees of freedom in cervical spine motion
Six Degrees of Freedom Motion

Movement Patterns

Translational Movements
Rotational Movements

Motion Coupling Relationships

The remarkable characteristic of natural disc motion involves coupling relationships where motion in one plane automatically influences motion in other planes through sophisticated mechanical properties of disc tissue and anatomical constraints. This coupled motion pattern enables efficient movement whilst maintaining physiological stability.

Design Challenge: Artificial disc systems must replicate these coupling patterns to achieve natural-feeling motion and prevent abnormal stress patterns on facet joints.

TGA-Approved Device

The PRESTIGE SystemMedtronic

The PRESTIGE system represents the foundation of modern cervical disc replacement technology, evolving through successive generations from the original Frenchay design developed by Steven Gill at Frenchay Hospital in Bristol. The system exemplifies the iterative development approach that transforms promising concepts into proven clinical solutions.

PRESTIGE LP Cervical Disc System
PRESTIGE LP System
Unconstrained

PRESTIGE LP Specifications

material

Titanium alloy (Ti-6Al-4V)

fixation

Anterior-engaging screws

coating

Titanium plasma spray

profile

Low profile design

Unconstrained Design Philosophy

The PRESTIGE employs an innovative unconstrained motion philosophy allowing the superior endplate to slide freely within the inferior endplate, enabling variable centre of rotation patterns that approximate natural disc kinematics.

Unconstrained metal-on-metal articulation
Variable centre of rotation patterns
Porous titanium coating (LP) for osseointegration
Reduced height minimising dysphagia risk
Relies on intact posterior ligaments for stability

FDA-Approved Clinical Evidence

The PRESTIGE system benefits from extensive clinical validation through large prospective randomised controlled trials. Long-term studies extending to 10 years confirmed maintained clinical benefit superior to ACDF.

Overall Success Rate (24mo)79.3%67.8% ACDF
NDI Improvement (10yr)54.6 → 19.2Sustained benefit
Patient Satisfaction (10yr)>90%
Adjacent Level Reoperation (10yr)13.8%Reduced vs fusion
Maintained Segmental Motion7-9°Long-term follow-up

Durability: The PRESTIGE system maintains exceptional durability with minimal implant-related complications. Metal-on-metal articulation provides proven wear resistance, and the unconstrained design optimises motion restoration with maintained segmental motion of 7-9 degrees at long-term follow-up.

TGA-Approved Device

The Bryan Cervical DiscMedtronic — Biomimetic Innovation

The Bryan disc represents a fundamentally different design philosophy emphasising biomimetic replication of natural disc properties rather than purely mechanical constraint approaches. The innovative system incorporates titanium endplates articulating with a polyurethane core bathed in saline.

Bryan Cervical Disc with polyurethane core and saline sheath
Bryan Cervical Disc
Biomimetic

Innovative Design Features

Press-Fit Fixation

Unconstrained press-fit philosophy allows the device to be secured without screws, eliminating screw-related complications whilst relying on appropriate implant-bone contact.

Saline-Filled Sheath

The saline-filled sheath provides crucial wear particle containment, preventing debris from entering surrounding tissues—an innovative approach addressing articulating implant concerns.

Polyurethane Core

Central polyurethane nucleus provides viscoelastic properties enabling progressive load deformation with elastic return, replicating natural disc tissue behaviour.

Long-term clinical studies extending to 10 years demonstrated outstanding performance, validating the biomimetic design approach with superior outcomes compared to ACDF.

Overall Success (10yr)81.3%66.3% ACDF
NDI Improvement38.3 pts31.1 pts fusion
Maintained Motion (10yr)9.0°Segmental ROM
Index Level Reoperation9.7%15.8% fusion
Patient Satisfaction>90%At extended follow-up

Patient Satisfaction: Greater than 90% of patients reported satisfaction at extended follow-up, with the vast majority reporting they would undergo the procedure again if necessary.

TGA-Approved Device

The ProDisc-C SystemCentinel Spine — Ball-and-Socket Design

The ProDisc-C represents the alternative ball-and-socket design philosophy to unconstrained systems, providing mechanical constraint through spherical articulation between cobalt-chromium endplates and an ultra-high-molecular-weight polyethylene (UHMWPE) core. This design draws proven principles from decades of successful hip and knee arthroplasty experience.

ProDisc-C ball-and-socket cervical disc implant
ProDisc-C System
Semi-Constrained

Ball-and-Socket Philosophy

The ball-and-socket articulation provides semi-constrained motion with fixed centre of rotation, offering mechanical simplicity and proven durability. The constrained design provides inherent stability particularly valuable in patients with compromised posterior elements or existing facet joint degeneration.

Superior mechanical strength for demanding loads
Proven UHMWPE durability from orthopaedic experience
Inherent stability for compromised posterior elements
Simplified surgical technique with predictable outcomes
Established long-term wear characteristics
EndplatesCobalt-Chromium Alloy
CoreUHMWPE

Modern Variants

ProDisc-C Nova: Enhanced fixation mechanisms with optimised geometry
ProDisc-C Vivo: Next-generation refinements for improved surgical outcomes

ProDisc-C demonstrated clinical equivalence to fusion in prospective randomised trials with long-term studies extending to 10 years confirming maintained clinical benefit.

81%Overall Success (24mo)Prospective RCT
7%Reoperation Rate (7yr)18% for fusion
6-8°Segmental MotionMaintained at follow-up
LowHeterotopic OssificationExcellent durability

Adjacent Segment Protection: Reoperation rates proved favourably low at 7% for ProDisc-C versus 18% for fusion at 7-year follow-up, demonstrating substantial adjacent segment protection despite the constrained mechanical design.

TGA-Approved Device

The Mobi-C SystemHighridge — Mobile Core Design

The Mobi-C represents an advanced semi-constrained design incorporating innovative geometric features providing controlled motion in all planes whilst maintaining inherent mechanical stability. The system exemplifies refinements attempting to optimise both motion restoration and constraint characteristics.

Mobi-C mobile-core cervical disc implant
Mobi-C System
Mobile Core

Design Innovation

EndplatesCobalt-Chromium
CoreUHMWPE Mobile

Clinical Performance

The Mobi-C achieved FDA approval with robust clinical evidence demonstrating superior outcomes compared to fusion, particularly impressive in two-level disease.

80.4%Two-Level Success62.2% fusion
88.4%NDI Success Rate76.5% fusion
10.9°Range of MotionHighest ROM
11.4%Reoperation (2yr)31% fusion

Recent comparative studies of 835 patients across four IDE trials demonstrated that two-thirds of implanted levels with PRESTIGE LP and Mobi-C achieved physiological motion ranges (5-16 degrees) at 24-month follow-up.

Superior Range of Motion

The Mobi-C consistently demonstrated 10.9° average ROM—the greatest range of motion compared to other semi-constrained designs in comparative studies. This superior motion preservation correlates with enhanced adjacent segment protection and improved functional outcomes.

TGA-Approved DeviceNEW 2025

MOVE-CNext-Generation Biomimetic Technology

The MOVE-C represents cutting-edge cervical disc replacement technology combining innovative features from different design philosophies whilst addressing limitations of previous approaches. The system received TGA approval in March 2025, bringing advanced viscoelastic technology to Australian patients.

MOVE-C next-generation cervical disc with PCU core
MOVE-C System
Viscoelastic

Regulatory Timeline

TGA Approval (Australia)March 2025
FDA PMA SubmissionAugust 2025

Design Innovation

Titanium alloy (TiAl6V4) endplates with additive manufacturing
Polycarbonate urethane (PCU) core for viscoelastic properties
TiNbN-coated superior endplate articulation surface
Progressive resistance to motion without mechanical stops
Lower bioactivity of wear particles vs cross-linked UHMWPE

Biomechanical Characteristics

The MOVE-C demonstrates exceptional biomechanical properties validated through comprehensive mechanical testing, with its PCU core providing qualitatively physiological behaviour.

Wear Rate1.54 mg/M cycles

Comparable to or superior to UHMWPE systems

Deformation PatternJ-Shaped Curve

Matches natural disc tissue responses

Motion Degrees6 DoF + Damping

Physiological motion with axial shock absorption

Early clinical experience with MOVE-C demonstrates favourable outcomes with excellent motion preservation and patient satisfaction. First clinical results from 48-month follow-up showed preserved segmental motion and clinical improvement comparable to established systems.

Metal-on-PCU Advantage

The articulation avoids limitations of both metal-on-metal systems (higher wear particles) and metal-on-UHMWPE approaches (less physiological behaviour).

FDA IDE Trials

Recent trials have met thresholds for non-inferiority claims against Mobi-C control device for both 1-level and 2-level indications.

TGA-Approved Device10-YEAR DATA

Baguera-CSpineArt — Semi-Constrained Viscoelastic Innovation

The Baguera-C represents a sophisticated semi-constrained design philosophy emphasising balanced motion preservation with shock-absorbing viscoelastic properties. Representing the reference device in the cervical arthroplasty segment globally, the Baguera-C combines advanced engineering with biomimetic principles.

Baguera-C with diamond-like carbon coating
Baguera-C System
DLC Coating

Revolutionary Design Features

Titanium alloy endplates with DLC coating
Diamond-like carbon reduces MRI artefacts
Mobile-core polyethylene nucleus
Superior wear resistance vs traditional metallic
Optimised for postoperative imaging assessment

Biomechanical Advantages

Clinical Performance at 10 Years

The Baguera-C benefits from exceptional long-term clinical validation, demonstrating outstanding durability and patient outcomes across a decade of follow-up.

82.7%Pain-Free at 10 Years
86.6%Motion Preserved
7.4°Average ROM
92%Patient Satisfaction
1%Reoperation Rate
0%Device Complications
0%Adjacent Segment Reop
18.5%Grade III-IV HO

Neurological Preservation

98.8% motricity and 96.3% sensation maintained at 10-year follow-up

Zero Adjacent Reops

No reoperations for adjacent level disease at 10 years—exceptional protection

TGA-Approved DeviceREVOLUTIONARY

CP-ESPOne-Piece Viscoelastic Innovation

The CP-ESP (Cervical Prosthesis - Elastic Spine Pad) represents a revolutionary one-piece viscoelastic cervical disc replacement concept evolved from over 20 years of research. Based on the successful LP-ESP lumbar disc technology, the CP-ESP brings proven viscoelastic principles with a fundamentally different approach from traditional articulating systems. TGA Registration: 17 January 2024

CP-ESP one-piece viscoelastic cervical disc
CP-ESP System
One-Piece

Revolutionary Design Principles

PCU Elastomer Technology

15+ years of development with advanced elastomeric formulation, proven biocompatibility, wear-resistant properties, and no biodegradation.

2-Year Post-Market Clinical Study

39 patients, single and two-level procedures

Neck Disability Index
48%4%
92% improvement
Neck Pain (VAS)
63 mm15 mm
76% improvement
Right Arm Pain
43 mm10 mm
77% improvement
Left Arm Pain
44 mm9 mm
80% improvement

Patient Satisfaction

83% “definitely” would choose same treatment, 11% “probably” would

Safety Profile

Zero device-related complications reported in any patient

Material Science

Advanced Biomechanical DesignMaterials and Surface Technologies

Material selection for cervical disc replacement involves sophisticated consideration of mechanical properties, biological compatibility, wear resistance, and imaging characteristics. Modern devices employ advanced metallurgy and polymer science optimised for the unique demands of spinal motion preservation.

Clinical Applications

Titanium Alloys (Ti-6Al-4V)

Used in:

PRESTIGE LP, MOVE-C, Baguera-C, CP-ESP endplates

Surface Treatment Technologies

Titanium Plasma Spray

Creates porous surface enabling direct bone on-growth

PRESTIGE LP

Hydroxyapatite (HA) Coating

Bioactive ceramic accelerating osseointegration

Various devices

Diamond-Like Carbon (DLC)

Ultra-hard, low-friction surface with minimal MRI artefacts

Baguera-C

TiNbN Coating

Titanium-niobium-nitride for enhanced wear resistance

MOVE-C superior surface

Additive Manufacturing

Porous structures mimicking trabecular bone architecture

MOVE-C endplates
Evidence Base

Clinical Outcomes EvidenceValidation Through Research

Contemporary cervical disc replacement benefits from extensive clinical validation through prospective randomised controlled trials, FDA IDE studies, and long-term registry data extending to 10+ years of follow-up.

Motion Preservation

6–10°Maintained ROM at 10 Years

Long-term studies consistently demonstrate maintained segmental motion

Segmental motion of 6-10° typically maintained at 10-year follow-up
Range of motion preserved across all approved device types
Motion preservation correlates with adjacent segment protection
Physiological kinematics maintained with appropriate implant selection
Outcome MetricArthroplastyACDF FusionAdvantage
Overall Success (24mo)79-81%63-68%+11-18%
NDI ImprovementSuperiorBaselineSignificant
Reoperation Rate (7yr)7-10%15-31%50% Lower
Motion Preserved6-10°Full ROM

Clinical Evidence Summary: Across multiple FDA IDE trials and long-term follow-up studies, cervical disc replacement consistently demonstrates superior or non-inferior outcomes compared to anterior cervical discectomy and fusion (ACDF), with the added benefit of motion preservation.

Device Comparison

TGA-Approved Cervical Disc SystemsComprehensive Comparison

Seven cervical disc replacement systems are currently approved by the Therapeutic Goods Administration (TGA) for use in Australia, each offering distinct design philosophies, material technologies, and clinical performance characteristics.

DesignUnconstrained
TGA StatusEstablished
EndplateTitanium Alloy
CoreMetal-on-Metal
Key FeaturesPorous Ti sprayLow profileFDA first approved
Clinical79.3% success, 7-9° ROM at 10yr
DesignUnconstrained
TGA StatusEstablished
EndplateTitanium
CorePolyurethane + Saline
Key FeaturesSaline sheathPress-fitWear containment
Clinical81.3% success, 9° motion at 10yr
DesignSemi-Constrained
TGA StatusEstablished
EndplateCobalt-Chrome
CoreUHMWPE
Key FeaturesKeeled fixationNova/Vivo variantsProven durability
Clinical81% success, 7% reop at 7yr
DesignSemi-Constrained
TGA StatusEstablished
EndplateCobalt-Chrome
CoreMobile UHMWPE
Key FeaturesSuperior sphericalInferior cylindricalTwo-level approved
Clinical80.4% success, 10.9° ROM
DesignViscoelastic
TGA StatusMarch 2025
EndplateTitanium + TiNbN
CorePCU
Key FeaturesAdditive manufacturingJ-curve deformationLow wear
Clinical1.54 mg/M cycle wear rate
DesignSemi-Constrained
TGA StatusEstablished
EndplateTitanium + DLC
CoreMobile PE
Key FeaturesDLC coatingMRI optimisedZero adjacent reop
Clinical82.7% pain-free, 1% reop at 10yr
DesignOne-Piece
TGA StatusJanuary 2024
EndplateTitanium
CorePCU Elastomer
Key FeaturesNo articulationElastic returnLowest NDI
Clinical4% NDI, 94% satisfaction at 2yr

Note: This comparison presents general device characteristics. Individual patient suitability depends on specific clinical circumstances, surgeon preference, and comprehensive preoperative assessment.

Selection Guidance

Implant Selection ConsiderationsPersonalised Device Selection

Optimal cervical disc replacement outcomes depend on matching device characteristics to individual patient requirements. Understanding design philosophy differences and patient-specific factors enables informed decision-making during surgical planning.

Design Philosophy Considerations

Patient-Specific Selection Factors

Comprehensive Assessment Required

This guidance outlines general selection principles. Individual implant selection requires comprehensive clinical assessment including detailed patient history, thorough physical examination, advanced imaging review, and discussion of individual patient goals and preferences. Your treating surgeon will recommend the most appropriate device based on your specific circumstances.

Summary

Evidence-Based Decision Making

Modern cervical disc replacement technology provides exceptional options for motion preservation, with seven TGA-approved devices offering proven clinical performance and sustained long-term outcomes.

Key Takeaways

Seven TGA-approved cervical disc systems offer complementary design approaches
Each device type addresses different patient requirements and clinical circumstances
10+ years of clinical evidence validates motion preservation as superior alternative to fusion
Adjacent segment protection substantially improved with disc replacement
Patient satisfaction consistently exceeds 90% across device types
Ongoing innovation continues advancing biomimetic technology

TGA-Approved Options

PRESTIGE LPUnconstrained sliding, extensive evidence
BryanBiomimetic saline sheath design
ProDisc-CProven ball-and-socket durability
Mobi-CSuperior two-level outcomes
MOVE-CNext-gen viscoelastic technology
Baguera-CDLC coating, zero adjacent reops
CP-ESPRevolutionary one-piece elastomer

Personalised Consultation

Understanding your individual circumstances is essential for optimal implant selection. A comprehensive consultation allows detailed assessment of your specific requirements, preferences, and treatment goals to determine the most appropriate approach.

Innovation Continues: Ongoing research and development continues advancing cervical disc replacement technology, with next-generation devices incorporating increasingly sophisticated biomimetic features and materials optimised for long-term performance.